Repligen
RGEN
#1854
Rank
โ‚ฌ10.05 B
Marketcap
157,30ย โ‚ฌ
Share price
6.47%
Change (1 day)
19.12%
Change (1 year)
Categories

Market capitalization of Repligen (RGEN)

Market cap: โ‚ฌ10.05 Billion

As of November 2026 Repligen has a market cap of โ‚ฌ10.05 Billion. This makes Repligen the world's 1854th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Repligen from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚ฌ10.05 B26.25%
2025โ‚ฌ7.96 B1.64%
2024โ‚ฌ7.83 B-13.71%
2023โ‚ฌ9.08 B3.62%
2022โ‚ฌ8.76 B-32.22%
2021โ‚ฌ12.92 B51.67%
2020โ‚ฌ8.52 B98.24%
2019โ‚ฌ4.30 B112.39%
2018โ‚ฌ2.02 B53.7%
2017โ‚ฌ1.31 B32.88%
2016โ‚ฌ0.99 B16.28%
2015โ‚ฌ0.85 B59.77%
2014โ‚ฌ0.53 B69.21%
2013โ‚ฌ0.31 B112.91%
2012โ‚ฌ0.14 B80.46%
2011โ‚ฌ82.06 M-24.4%
2010โ‚ฌ0.10 B23.01%
2009โ‚ฌ88.24 M4.66%
2008โ‚ฌ84.31 M-39.48%
2007โ‚ฌ0.13 B115.29%
2006โ‚ฌ64.7 M-36.36%
2005โ‚ฌ0.10 B59.25%
2004โ‚ฌ63.85 M-38.56%
2003โ‚ฌ0.10 B30.7%
2002โ‚ฌ79.5 M8.19%
2001โ‚ฌ73.48 M-22.84%
2000โ‚ฌ95.24 M37.4%
1999โ‚ฌ69.32 M256.72%
1998โ‚ฌ19.43 M64.02%
1997โ‚ฌ11.84 M-25.58%
1996โ‚ฌ15.92 M

End of Day market cap according to different sources

On Nov 17th, 2026 the market cap of Repligen was reported to be:

โ‚ฌ9.44 Billion
by Nasdaq info icon info icon
โ‚ฌ9.44 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
โ‚ฌ145.70 B 1,349.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
โ‚ฌ233.82 B 2,225.40%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
โ‚ฌ308.86 B 2,971.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ110.91 B 1,003.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
โ‚ฌ27.92 M-99.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
โ‚ฌ1.19 B-88.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚ฌ15.01 B 49.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
โ‚ฌ10.41 B 3.54%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚ฌ10.83 B 7.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
โ‚ฌ14.54 B 44.67%๐Ÿ‡บ๐Ÿ‡ธ USA